The evaluation involved measuring serum levels of key biomarkers associated with liver fibrosis, including fibronectin (FN), hyaluronic acid (HA), and transforming growth factor beta-1 (TGF-β1). The gene discussed is TGFB1; the disease is Hepatic fibrosis.